Taysha Releases Financial, Enrollment Update and Community Letter

Taysha provided an update today on their Rett syndrome gene therapy trial of TSHA-120.  The updates cover enrollment, recent FDA interactions and financial information.  No new clinical  information shared at this time. For details please see the resources below.